These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7930190)
1. Predicting the risk of abrupt vessel closure after angioplasty in an individual patient. Tenaglia AN; Fortin DF; Califf RM; Frid DJ; Nelson CL; Gardner L; Miller M; Navetta FI; Smith JE; Tcheng JE J Am Coll Cardiol; 1994 Oct; 24(4):1004-11. PubMed ID: 7930190 [TBL] [Abstract][Full Text] [Related]
2. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. Tan K; Sulke N; Taub N; Sowton E J Am Coll Cardiol; 1995 Mar; 25(4):855-65. PubMed ID: 7884088 [TBL] [Abstract][Full Text] [Related]
10. The relation of clinical outcome to dissection and thrombus formation during coronary angioplasty. Heparin Registry Investigators. Ferguson JJ; Barasch E; Wilson JM; Strony J; Wolfe MW; Schweiger MJ; Leya F; Bonan R; Isner JM; Roubin GS J Invasive Cardiol; 1995; 7(1):2-10. PubMed ID: 10155653 [TBL] [Abstract][Full Text] [Related]
11. Abrupt (< 1 day), acute (< 1 week), and early (< 1 month) vessel closure at the angioplasty site. Morphologic observations and causes of closure in 130 necropsy patients undergoing coronary angioplasty. Waller BF; Fry ET; Peters TF; Hermiller JB; Orr CM; VanTassel J; Pinkerton CA Clin Cardiol; 1996 Nov; 19(11):857-68. PubMed ID: 8914779 [TBL] [Abstract][Full Text] [Related]
12. Matching based on quantitative coronary angiography as a surrogate for randomized studies: comparison between stent implantation and balloon angioplasty of native coronary artery lesions. de Jaegere PP; Hermans WR; Rensing BJ; Strauss BH; de Feyter PJ; Serruys PW Am Heart J; 1993 Feb; 125(2 Pt 1):310-9. PubMed ID: 8427121 [TBL] [Abstract][Full Text] [Related]
13. Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. Sutton JM; Ellis SG; Roubin GS; Pinkerton CA; King SB; Raizner AE; Holmes DR; Kereiakes DJ; Topol EJ Circulation; 1994 Mar; 89(3):1126-37. PubMed ID: 8124799 [TBL] [Abstract][Full Text] [Related]
14. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty. Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156 [TBL] [Abstract][Full Text] [Related]
15. Abrupt vessel closure after directional coronary atherectomy. The U.S. Directional Atherectomy Investigator Group. Popma JJ; Topol EJ; Hinohara T; Pinkerton CA; Baim DS; King SB; Holmes DR; Whitlow PL; Kereiakes DJ; Hartzler GO J Am Coll Cardiol; 1992 Jun; 19(7):1372-9. PubMed ID: 1593028 [TBL] [Abstract][Full Text] [Related]
16. Abrupt closure: the CAVEAT I experience. Coronary Angioplasty Versus Excisional Atherectomy Trial. Holmes DR; Simpson JB; Berdan LG; Gottlieb RS; Leya F; Keeler GP; Califf RM; Topol EJ J Am Coll Cardiol; 1995 Nov; 26(6):1494-500. PubMed ID: 7594076 [TBL] [Abstract][Full Text] [Related]
17. Length of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators. Wolfe MW; Roubin GS; Schweiger M; Isner JM; Ferguson JJ; Cannon AD; Cleman M; Cabin H; Leya F; Bonan R Circulation; 1995 Aug; 92(3):311-9. PubMed ID: 7634443 [TBL] [Abstract][Full Text] [Related]